Literature DB >> 8410524

Gamma globulin re-treatment in Kawasaki disease.

R P Sundel1, J C Burns, A Baker, A S Beiser, J W Newburger.   

Abstract

We retrospectively reviewed the effects of intravenous gamma-globulin (IVGG) re-treatment of 13 children with Kawasaki disease and persistent or recrudescent fever. Fever and mucocutaneous inflammation resolved within 48 hours in nine patients; fever abated in two other children after a third course of IVGG. We conclude that IVGG re-treatment of Kawasaki disease appears to be safe and may improve the clinical course.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8410524     DOI： 10.1016/s0022-3476(05)80972-2

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


  56 in total

Review 1.  Update on the treatment of Kawasaki disease in childhood.

Authors:  Robert P Sundel
Journal:  Curr Rheumatol Rep       Date:  2002-12       Impact factor: 4.592

Review 2.  New perspectives in the drug treatment of Kawasaki disease.

Authors:  D Shingadia; S T Shulman
Journal:  Paediatr Drugs       Date:  1999 Oct-Dec       Impact factor: 3.022

3.  Coronary risk factors in Kawasaki disease treated with additional gammaglobulin.

Authors:  M Miura; H Ohki; T Tsuchihashi; H Yamagishi; Y Katada; K Yamada; Y Yamashita; A Sugaya; O Komiyama; H Shiro
Journal:  Arch Dis Child       Date:  2004-08       Impact factor: 3.791

Review 4.  Overview of pharmacological treatment of Kawasaki disease.

Authors:  Z Onouchi; T Kawasaki
Journal:  Drugs       Date:  1999-11       Impact factor: 9.546

Review 5.  Kawasaki Disease update.

Authors:  Jane C Burns
Journal:  Indian J Pediatr       Date:  2009-04-18       Impact factor: 1.967

6.  Infliximab treatment of intravenous immunoglobulin-resistant Kawasaki disease.

Authors:  Jane C Burns; Brookie M Best; Asuncion Mejias; Lynn Mahony; David E Fixler; Hasan S Jafri; Marian E Melish; Mary Anne Jackson; Basim I Asmar; David J Lang; James D Connor; Edmund V Capparelli; Monica L Keen; Khalid Mamun; Gregory F Keenan; Octavio Ramilo
Journal:  J Pediatr       Date:  2008-07-30       Impact factor: 4.406

Review 7.  Superantigens related to Kawasaki syndrome.

Authors:  D Y Leung
Journal:  Springer Semin Immunopathol       Date:  1996

8.  Recognizing Kawasaki disease.

Authors:  B Lang
Journal:  Paediatr Child Health       Date:  2001-11       Impact factor: 2.253

Review 9.  The Complexities of the Diagnosis and Management of Kawasaki Disease.

Authors:  Anne H Rowley
Journal:  Infect Dis Clin North Am       Date:  2015-07-04       Impact factor: 5.982

10.  Low-dose methotrexate therapy for intravenous immunoglobulin-resistant Kawasaki disease.

Authors:  Taek Jin Lee; Ki Hwan Kim; Jin-Kyong Chun; Dong Soo Kim
Journal:  Yonsei Med J       Date:  2008-10-31       Impact factor: 2.759
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.